<DOC>
	<DOCNO>NCT00771160</DOCNO>
	<brief_summary>A clinical study evaluate efficacy safety MK0476 adult patient Perennial Allergic rhinitis .</brief_summary>
	<brief_title>MK0476 Study Adult Patients With Perennial Allergic Rhinitis ( 0476-397 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Adult Patients With Perennial Allergic Rhinitis Patients Who Have Nasal Diseases ( E.G. , Nasal Polyp , Septonasal Arcuation , Hypertrophic Rhinitis ) , Upper Respiratory Infection , Sinusitis , Infectious Rhinitis And Those Disease Severe Enough To Interfere With Assessment Of Effectiveness Patients Who Have Rhinitis Medicamentosa , Or Nonallergic Rhinitis ( E.G. , Vasomotor Rhinitis , Eosinophilia Rhinitis ) Patient Has A Disease Of The Cardiovascular , Hepatic , Renal , Hematologic Systems , Or Other Severe Disease</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>